Glycosylated Siglec-6 expression in syncytiotrophoblast-derived extracellular vesicles from preeclampsia placentas
- 17 December 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 533 (4), 838-844
- https://doi.org/10.1016/j.bbrc.2020.09.081
Abstract
No abstract availableFunding Information
- National Institute of Health Research Clinical Research Network
This publication has 42 references indexed in Scilit:
- Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasionEndocrine-Related Cancer, 2012
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathwaysPlacenta, 2011
- Differential Placental Gene Expression in Severe PreeclampsiaPlacenta, 2009
- Differential placental gene expression in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Severe Preeclampsia-Related Changes in Gene Expression at the Maternal-Fetal Interface Include Sialic Acid-Binding Immunoglobulin-Like Lectin-6 and Pappalysin-2Endocrinology, 2008
- Targeting selectins and selectin ligands in inflammation and cancerEmerging Therapeutic Targets, 2007
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsBlood, 2007
- Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cellsAllergy, 2006